FDA 483 - Louise Charest, M.D. - September 29, 2017

An FDA inspection of Clinique Medicale L'Actuel, a clinical investigator, revealed a significant deficiency in obtaining legally effective informed consent. A subject in a clinical trial was administered study drug and underwent related tests after signing an informed consent form for a different study protocol. This lapse resulted in the subject participating in the study without appropriate consent.